Hosvilda 50mg Tablet

Hosvilda 50mg Tablet contains Metformin and Vildagliptin as active components. It is indicated for the management of type 2 diabetes mellitus, a chronic condition affecting how the body processes blood sugar (glucose). This medication helps control elevated blood sugar levels and may improve insulin sensitivity in patients with insulin resistance. It may be used to manage blood sugar levels in individuals with overweight and obesity-related metabolic disorders.

This medication is contraindicated in patients with known hypersensitivity or allergy to Hosvilda 50mg Tablet or any inactive ingredients. It should not be used in patients with severe renal impairment (creatinine clearance below 30 mL/min), as the kidneys primarily excrete this medication and clearance is reduced in renal dysfunction. Patients with a history of ketoacidosis, diabetic ketoacidosis, or lactic acidosis should not use this medication. It is not recommended for patients with severe liver impairment. Conditions including heart failure, respiratory failure, recent myocardial infarction, and shock, which may lead to tissue hypoxia, are contraindications. In patients receiving iodinated contrast agents for radiologic studies, this medication should be temporarily discontinued before or at the time of the procedure and not restarted until at least 48 hours after, provided renal function has been re-evaluated and found to be stable.

Elderly patients may be more susceptible to side effects of this medication, particularly those related to kidney function. Regular monitoring of kidney function is essential. Hosvilda 50mg Tablet is not recommended for use in children.

Management of type 2 diabetes mellitus Control of hyperglycemia Improvement of insulin sensitivity Weight management

Hosvilda 50mg Tablet works by combining the mechanisms of its two active ingredients, Vildagliptin and Metformin, to manage type 2 diabetes mellitus. Vildagliptin functions by inhibiting the enzyme DPP-4, which increases active incretin hormone levels, stimulating insulin secretion and reducing glucagon release. Metformin reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity through AMPK activation. This combined action helps regulate blood sugar levels through complementary pathways.

Hosvilda 50mg Tablet is administered orally as tablets. The recommended starting dosage and any necessary dose adjustments are determined based on the specific condition being treated and the patient's response to the medication.

Hosvilda 50mg Tablet causes some side effects like all medications, although not everyone will experience them. Serious Lactic acidosis Severe allergic reactions Common Gastrointestinal disturbances Hypoglycemia Headache Dizziness Weakness or fatigue Metallic taste in the mouth

Regularly check kidney function as Hosvilda 50mg Tablet is eliminated through the kidneys. Be cautious of low blood sugar levels, especially when taking other diabetes medications. Watch for symptoms of lactic acidosis and seek immediate medical help if experienced. Temporarily stop medication before using contrast agents for medical tests. Use with care in patients with liver problems and be mindful of any signs of infection. Inform healthcare providers about the medication before any surgery or medical procedures. Be aware of potential allergic reactions and report any promptly. Monitor for vitamin B12 deficiency during long-term use and consider supplementation if needed. Stay hydrated, especially during illness or in hot weather, to prevent dehydration complications. Consult a healthcare provider for any changes in management during periods of stress, like surgery or infections. Use with caution during pregnancy and lactation, and discuss potential risks and benefits with a healthcare provider.